News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis Corporation (NVS) Drug Fails To Stop Atrial Fibrillation, ANMCO Research Center Study



4/16/2009 7:03:22 AM

BOSTON, April 15 (Reuters) - A high dose of Novartis's (NOVN.VX) blood pressure drug Diovan failed to prevent recurrences of atrial fibrillation, the common irregular beating of the heart that can increase the risk of stroke, Italian researchers reported on Wednesday.

Read at HealthDay
Read at Reuters
Read at MedPageToday


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES